back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-08 11:58 Tx date 2026-09-04 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,703 vol |
241,306 | |
| Filed 2026-08-28 17:23 Tx date 2026-08-28 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$111,832
+21,928 vol $5.10 each |
239,603 | |
| Filed 2026-08-28 17:22 Tx date 2026-08-28 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-111,832.80
-21,928 vol $5.10 each |
877,402 | |
| Filed 2026-08-28 09:52 Tx date 2026-08-27 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,259,690.76
-106,844 vol $11.79 each |
217,675 | |
| Filed 2026-08-04 11:06 Tx date 2026-08-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,703 vol |
324,519 | |
| Filed 2026-07-03 11:32 Tx date 2026-07-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,703 vol |
322,816 | |
| Filed 2026-06-04 12:56 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,703 vol |
321,113 | |
| Filed 2026-05-05 11:25 Tx date 2026-05-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,703 vol |
319,410 | |
| Filed 2026-04-02 17:20 Tx date 2026-03-31 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$692,400
+120,000 vol $5.77 each |
899,330 | |
| Filed 2026-04-01 12:43 Tx date 2026-03-31 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+29,207 vol |
317,707 | |
| Filed 2026-03-03 11:23 Tx date 2026-03-02 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,191 vol |
288,500 | |
| Filed 2026-02-24 15:48 Tx date 2026-02-19 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+27,285 vol |
287,309 | |
| Filed 2026-02-24 15:47 Tx date 2026-02-19 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,996
+2,450 vol $4.08 each |
260,024 | |
| Filed 2026-02-24 15:46 Tx date 2026-02-19 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-9,996
-2,450 vol $4.08 each |
779,330 | |
| Filed 2026-02-02 15:47 Tx date 2026-02-02 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,558 vol |
257,574 | |
| Filed 2026-01-16 12:59 Tx date 2026-01-14 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,500
+10,000 vol $2.45 each |
256,016 | |
| Filed 2026-01-16 12:58 Tx date 2026-01-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-24,500
-10,000 vol $2.45 each |
781,780 | |
| Filed 2026-01-08 10:13 Tx date 2026-01-07 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,750
+14,184 vol $2.45 each |
246,016 | |
| Filed 2026-01-08 10:12 Tx date 2026-01-07 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-34,750.80
-14,184 vol $2.45 each |
791,780 | |
| Filed 2026-01-05 12:29 Tx date 2026-01-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,382 vol |
231,832 |